Välkomna ! En regionaliserad myndighet Insynsråd Generaldirektör Internrevision Generaldirektörens Avdelningen för verksamhetsstöd och –styrning stab Rättsenheten Avdelningen för analys och utveckling Avdelning nord Avdelning mitt UMEÅ ÖREBRO Avdelning öst STOCKHOLM Avdelningen för Tillståndsprövning STOCKHOLM *Nationell samordning av Blod- vävnad/cell och organ hantering Avdelning sydöst Avdelning sydväst Avdelning syd JÖNKÖPING GÖTEBORG MALMÖ Analys- Tillsynsåterföring- Vägledning IVO ska regelbundet analysera och dra generella slutsatser av de brister och missförhållanden som myndigheten ser i verksamheterna inom hälso- och sjukvård och socialtjänst IVO ska återföra brett vad myndigheten ser i tillsynen för ett systematiskt lärande och för att undvika att brister och missförhållanden upprepas IVO ska inom ramen för sin tillsyn lämna råd och ge vägledning till verksamheterna i vård och omsorg - Programpunkter 9-12 Informationsöverföring (2012/25/EU) ”delegerade inrättningar” SOSFS 2015:6 Samverkan SoS-IVO Senaste nytt donationsutredningen Avvikelser / biverkningar Årsrapporter Inspektioner Direktiv 2012/25/EU • Informationsöverföring mellan medlemsstater när organ överförs mellan medlemstater. –Förordning 2012:346 (2014:831) –SOSFS 2015:6 Direktiv 2012/25/EU IVO ´s skyldigheter enligt direktivet: – Utse de svenska delegerade inrättningarna = vårdgivarna som ansvarar för transplantation – Upprätthålla register över kontaktuppgifter till myndighet och delegerade inrättningar – http://txcontactlist.eu/ – Mottagare av anmälningar av avvikande händelser / biverkningar Delegerade inrättningars skyldigheter enligt direktivet: • Vidarebefordra/ mottaga uppgifter om organet (24/7) • Vidarebefordra/ mottaga uppgifter om avvikande händelser och biverkningar (24/7) • Anmäla avvikande händelser / biverkningar till IVO • SOSFS 2015:6 • Samverkan mellan SoS och IVO • Donationsutredningen ? Samverkan IVO-SoS avseende rapporter till EU • Transposition av Direktiv – Vilken svensk lag/ föreskrift motsvarar /. • Implementering av Direktiv (nyheter) – Hur följer SE (verksamheterna) Direktivet • • • • Frivillig obetald donation (opt-in /opt-out) Årsrapporten (hur många rapporterar) Hur många inspektioner görs Hur många organ exporteras / importeras • Olika EU-projekt som ska kartlägga ”hur det ser ut” E""!'ean Convnission Main sections in the survey... and in the final report: A - Identification of Competent authorities and overall set-up (i ncl ud in g Articles 17: tasks, 21: EOEOs, and reg iona I leve I) B - Organ procurement, donor and recipient protection (art. 5, 6, 7, 12, 14) including authorisation of procurement centres, organ and donor ch ara cterisation, consent, person nel etc. C - Transport (art. 8) D - Organ transplantation (art. 9, 12) including authorisation of tra nspla nt cent res, person n el etc. E - Framework for quality and safety (art. 4, 17) including control/a ud its, issu e of guida n ce to h ea lthca re esta blish ments etc. F - General comments 4 15 Number of CAs declared at national level (corrected - but still to be confirmed via fo llow-up questions) 15 ~------- 12 + - - - -t-1'1-- - - 9 6 +-- 3 +-- 0 -+--- +-- 3 1 CA: BE, BG, CY, DE, DK, EE, ES, HR, LU, NO 2 C/ls: AT, CZ, EL, FI, FR, IE, IT, MT, PL, PT, RO, SE, SI, SK, UK 3 C/ls: LV, NL, HU 4 CAs: LT E..-opean Convnission Does the authorisation of procurement organisations: lnclude authorisation for all type of donors (DBD, DCD, LD)? Tvoe YES No. of counlries 14 NO 9 NIA 6 7 Original answers, not yet corrected I double-checked (also with answers to other questions) Does the authorisation of procurement organisations include authorisation to retrieve all organs from a donor? Counlries YES: AT, BE, ev, cz, DE, ES, FI, HR, IT, LU, LV, MT, AT, BE, CY, CZ, ES, FI, IE, rr, LV, MT, PT, s1, SK, UK BG, DE, EL, HU, HR, LU, PL, NO, RO ··: ~:~~:~··:··· ... : ~~~~:~: : ~~~~:~: :~~~,. BG, PT, NO, RO, SI, SK, UK; H~~;E, /~l~1:!~j~]~jw~: : · 18 PL; 4 ~~~~ OK. EE. FR. LT. NL. SE Does the authorisation of POs include authorisation for all type of donors (DBD, DCD, LD)? 7 YES in 14/29 MS Does the authorisation of procurement organisations include authorisation to retrieve all organs from a donor? 7YES in 18/29 MS 7 It seems that general authorisations schemes are prefered for POs E""Pean Commission How do you make sure that the healthcare personnel involved in the donation and procurementare suitably qualified or trained and competent? 20 20 ~Original answers, not yet corrected I double-checked (also with answers to other questions) 10 7 3 AT, BG, CZ, DE, DK, EL, FR, HR, BG, CZ, DE, DK, EL, FR, HR, IE, BG, CZ, DE, EL, HR, IE, IT, NO, IE, IT, LT, LU, LV, MT, NL, NO, IT, LT, LU, LV, MT, NL, NO, PL, PL, SI PL, SE, SI, SK PT, SE, SI, SK CY, FI, FR, LV, PT, RO, UK BE, EE,ES Through regular training program mes other Countries t hat did not answer At the moment of re cruitment (qualifi cations) Through certifi cation The 2 main methods to make sure that healthcare personnel involved in procurement activities are suitably qualified or trained and competent are: - At the moment of recruitment (20/29) - Through regular training program mes (20/29) 16 Elnpean Convnission Numbe r of Member States who declared to have operating procedures in place ('Are in your Member State operating procedures adopted and implemented for. .. ?') 30 25 25 26 25 26 26 25 25 25 20 15 10 5 0 ~ ~ ~~~~~~~ ~~ ~~~~~~~~~ ~ ~~~~~~~ CZ, DE, DK, EE, CZ, DE, D K, EE, CZ, DE, DK, EE, CZ, DE, DK, EE, CZ, DE, D K, EE, DE, DK, EE, EL, D E, DK, EE, EL, El , ES, FJ, FR, EL, ES, Fl, FR, El, ES, FJ, FR, EL, ES, Fl, FR, ES, FJ, FR, HR, El, ES, Fl, FR, ES, FJ, FR, HR, HR, IT, LT, LU, H R, IT, LT, LU, HR,. HU, IT, LT, H R, H U, IT, LT, HR, H U, IT, LT, HU, IT, LT, LU, H U, IT, LT, LU, LV, MT, NL, NO, LV, MT , NL, NO, LU, LV, MT, N L, LU, LV, MT, NL, LU, LV, MT , NL, LV, MT, NL, NO, LV, MT, NL, NO, LV, MT , NL, NO, PL, SE, SI, SK, PL, SE, SI, SK, UK UK NO, PL, SE, SI, NO, PL, SE, SI, SK, UK d( l) The d(2) The d(3) The P<Ocurement of l)<eservat lon of OfQ?ln!=:; in OfQ(')n~ in packaging of OrQ?lfl$;. in r SK, UK d(4) The labelllng of OfQ?ln~ in NO, PL, SE, SI, UK e) The F) EnsurinJ transportatlon of traceability, in OrQ?lll.C:: In accordance w ith accorda nce with acoo rdance w ith accordance w ith accordance with Artld es 5, 6 and Artldes 5, 6 and Artid es 5, 6 and 8 8 8 tldes 5, 6 and PL, SE, SI, SK, SK, UK Artld e 8 8 ;,c;m rt1;,n~ w ith PL, SE, SI, SK, PL, SE, SI, SK, UK UK g ) The h) The accurate, rapid management of ?ln<1 VP.rif i?thlP. ~P.f iOll~ ?l<IVP.f!=:;P. Artide 10, reporäng of events and guarant eelng serlous adverse reactlons In compliance with the un ion and advents and reac:äons in acco rdance w ith Article 11(2) . national accorda nce w lth provis ions :>n the protection Artide 1 1( 1). on personal data and conf identla lity Missing countries dl1l dl2l dl3l dl4l e f 0 h HU,IE. RO, PT HU, IE. RO, PT IE,RO, PT IE,RO, PT IE. RO, PT AT, IE. RC, PT AT, IE. RO, PT AT,IE. RO,PT 28 Working Group on lndicators under the Action Plan on Organ donation and transplantation 2014 Exercise - CA meeting on 11-12 March 2014 1. Donation 2. Waiting lists 3. Allocation 4. Transplantation 5. Health outcomes 6. Health resources 5. HEALTH OUTCOMES - SELECTED INDICATORS lndicators • • Registries (per organ) 1 year survival of • Grafts • Patients • Per organ Definitions Data-Sources • • Need to know no. of patients monitored (nominator) EC survey (excel) (31 countries replied for the 2014 exercise but data only partially available for health outcomes) Samverkan IVO-SoS avseende sakfrågor (statistik, föreskrifter, information till /från Soc-departementet). • IVO rapporterar vävnadsstatistik (avlidna donatorer) till livsviktigt. se • SoS informerar IVO om – Nyheter i föreskrifter – Aktuell / Säsongsberoende smittinfo • Utbyter minnesanteckningar från CA –möten • SoS och IVO har inloggning till RATC RAPID RISKASSESSMENT I • Invasive ca nfiovascular: infection by Mycobacttrlum chlm1111r11 potential!)'. associated with heater-cooler units used Cluring cardi!'lc surge!)'. 1•~ pdate \!Z,e.Rril 2015 Main conclusions and options for response Shce lJly 20:4, ten cases of hvasWe cardbvascular infection caused by Mycobactetir.Kn chin aera, hcl.Jdhg four fatal outcomes, have been detected n patients who had prevbustt undergone ccrdac surgery in Swi'2erL:ind, the Netherlands and Gernany. Aerosolsatbn of water from t~e heater-cooler unts for extracorporeal cf'cuL:ition in the operating room .......as consi:lered the most pL:iusbe route of infectbn. Heathcare prJviders involved in caring for patents vJ-io have undergone open-heart surgery shoukj be viaiant for cases of endocardtis or other cardbvascular infectbn of uni:lentifed ori;lin and consider testhg speciftcally for sb\o'rgrowhg non-tubercl.bus m ycobacteria such as Mycobactetir.Kn chinaera. Regulatory bodies n charge of li:ensing and agencies m onitoring the safety of such devices should be aware of the potential associatbn of nvasive cardiJvascuL:ir Ofections caused by Mycobacteriln chinae.i-a with heater-cooer units reported by Sax et al. [ 1) and reevant inform atbn should be dissem inated to al centres perfom ing cardiac surgery, ECDC is unde·talQng further work to evalJate the publc heath inpa:t of invasWe cardiovascuL:i· Ofectbn by Mycobactetir.Kn chin aera associated wth heater~ooler units, and wll publish an updated risk assessment as soon as this evaluatDn has been com pleted . • SOSFS 2015:6 • Samverkan mellan SoS och IVO • Donationsutredningen Rapportering av avvikande händelser / biverkningar Definition av avvikande händelse / biverkning När – till vem ska det rapporteras ? preliminär anmälan -IVO slutlig anmälan -IVO Vad ska rapporteras ? kontaktuppgifter, donators-ID (Sct –ID + SE) löpnr på anmälan (del 1 –del 2) ert Avvikelsenr beskrivning av händelsen / orsak Vidtagna åtgärder (initiala / för att minska risken för upprepning) CONSEQUENCES OF RECURRENCE IMPACT LEVEL 0 Insignificant 1 Minor 2 Moderate 3 Major 4 Catastrophic /Extreme INDIVIDUAL SYSTEM OTC SUPPLY Nil No effect Insignificant Non serious Minor damage Some applications postponed Serious Damage for short period Many cancellations or postponements Life threatening Major damage to system –significant delay to repair Significant cancellations Death System destroyed need to rebuild All allogenic applications cancelled Risk-Matris: Vad ska anmälas till IVO och vad ska anmälan leda till ? Likelihood of recurrence Consequences of recurrence Rare 1 Unlikely 2 Possible 3 Likely 4 Probable 5 Insignificant 0 0 0 0 0 0 Minor 1 1 2 3 4 5 Moderate 2 2 4 6 8 10 Major 3 3 6 9 12 15 Catastrophic 4 4 8 12 16 20 Rapporterade avvikelser (biverkning) 3 2 * * 1 2012 2013 2014 2015 0 * Förlorade organ: 2 njurar, 1 hjärta f'.JOT'F~ LIBRARY Centro Nazionale Trapianu --Coon ------ ltalianNatiooalTransplant Centre Tile Global Vigilance and Surveillance Oatabase for Medical Products of Human Origin ~• sr JSIC:h ID THE NOTIFY PROJECT + SEARCH LIBRARY Home I Search Ubrary I Adverse occurrence ~earch Adverse occurrence search Adverse occurrence type CExpand alll CClearl Harm toa Recipient Harm to ;i Oonor Harm toa Fetus or Offspring Rlskof harm Medical Products of Human Ongm type - MPHO CExpand all) CClearl Organs Blood - ~-S......flr ,, S E(, cPRODUCTION NOTIFY BOOKLET + BACKGROUND DOCUMENTS Medical Products of Human Origin type - MPHO CExpandalll CClearl Organs Kidney Liver Lung Pancreas Smallbowel Combined Type not specified Blood Cells .. .. Anmälan SAR/SAE • www.notifylibrary.org harm to recipient : Njurar: 200 exempel Hjärta: 38 exempel Conference & Workshop on Human Transplants Identification and Monitoring in European Union Katowice, 6-7 October 2011 Slides: courtesy of Prof. J. Wałaszewski Zbigniew Włodarczyk Reporting SARE (Directive 2010/53/EU) • Life threatening complication to other recipients,SARE must be reported immediately to CA (competent authority) • Unexpected or potential SARE, institution detecting SARE must immediately report this to the CA • CA must record all unexpected or potential SARE • An annual SARE report must be produced by CA of each member state and published by Council of Europe • All SARE data should be shared by all CAs in European SARE registry Zbigniew Włodarczyk Probability of donor's neoplasias transmission • ONT Registry (1990-2006) - undetectd tumors 5.8/1000 donors .Only 5 or 2.9/10,000 donors tumors were transmitted to the recipient, 10 out of 155(6.4%) or 2.2 per 10,000 recipients who received graft with a tumor developed tumoral transmission • Danish Registry- 13 malignant tumors among 626 donors (2%) during 27 y. 8 were detected after organ transplantation (1.3%) but only one transmitted neoplasia Zbigniew Włodarczyk Medical error: lungs ,,size error" • A nurse put in wrong figure inta computerised organ matching service : donar -156 cm tall, recipient 151cm • Surgeon was forced to compress oversized lung inta the chest.Transplant team discovered later that the donar was 165 cm tall. • Recipient developed pneumonia and died two months later. The surgeon attributed the death of the patient to the wrong size of transplanted lungs. Zbigniew Włodarczyk Nej Zbigniew Włodarczyk SAE & denominator Total nr of tissues and cells processed (thousand units): 2010-2012 data 1000000 Total number of SAE : 2010-2012 data 887536 900000 800000 • Ot her 700000 • Human error 600000 • Equipment failure 500000 400000 • Tissue/cell defect 300000 200000 100000 2010 0 2010 2011 2012 2011 YEAR 2012 Fråga från Er /Scandiatransplant: Kan vi rapportera till Sct som rapporterar till IVO? Svar från SE :NEJ Svar från FI : NEJ Svar från DK: NEJ Hur använder IVO anmälda avvikelser / biverkningar ? • Nationell överblick • Underlag inför inspektioner • Rapportering till EU med resultat att vi får en jämförelse SE- övriga EU länder. Årsrapporten – Vilka uppgifter behöver IVO ! • Antal donatorer - som ni (er tx-koordinator) ansvarat för • Antal organ som tillvaratagits (av er) • Antal mottagna från annan -inom Norden- inom EU /EES utom EU/EES) Ska vi skilja på SE, Norden-EES ? • Antal som lämnats till annan inom Norden, EES , utom EES eller till VI • Antal transplantationer som ni ansvarat för • Antal mottagare • Antal Lämnade till VI • Ej använda Levande / avlidna donatorer Transplantationsverksamhet 2013 • Levande Donatorer: 162 • Mottagare : 162 • Avlidna Donatorer: 150 (151) • Mottagare: 541 (från årsrapporten till IVO ) 791 organ varav 698 transplanterade (Ca 200 ”IMP/EXP”) Lämnat till VI : 93 organ (hjärta, pancreas) Ö-celler : 19 (16) http://www.ivo.se/globalassets/dokument/publicerat material/blanketter/donations--och-transplantationsverksamheter/arlig rapport-fran-transplantationscentrum-5-4.pdf SE / Norden ? Inspektion: • Olika organisation Rikssjukvård (njurar, tunntarm, livmoder ?) • Att dokumenterade rutiner, avtal, ansvar, samtycke, spårbarhet • Hur följs processer/rutiner/SOP ? • Scandiatransplant (spårbarheten) • Informationssäkerhet ? (behörigheter, egenkontroller? Dokumentation – Spårbarhet • Tillvaratagande rapport: don ID, uppgifter om samtycke, medicinsk information, tillvaratagandet , eventuella avvikande händelser / vem signerar vad ? • Spårbarhet: Donatorskod ( + SE ) • vem har gjort vad , instrument- apparatur- lösningar som är väsentliga för organets kvalitet, • Tillvaratagande; vävnader + organ; vävnadsinrättning – transplantationscentra -organ • Bevaras i 30 år Egenkontroller – ledningens genomgång • Resultat från internrevisioner (även av avtalspartners) – Vertikal revision (följa en/flera donationer hela kedjan av arbetsmoment) • Protokoll från ledningens genomgång Avvikelser Revisioner Personal Kvalitetssystemet (behövs uppdateringar / revideras) Övrig information från • Certifiering av transplantationskoordinatorer ? http://www.uemssurg.org/divisions/transplantation/transplant coordination/ebsq-examination • Ny rapport (mars-2015) från ECDC om HTLV-1 prevalens (litteratur översikt avseende aktivering av HTLV efter tx hos HTLV+ patienter) http://ecdc.europa.eu/en/publications/Publications/geographical distribution-areas-high-prevalence-HTLV1.pdf *** ** U. E.~' M.S. ** * . * *** Members Area I Contact UNION EUROPEENNE DES MEDECINS SPECIALISTES EUROPEAN UNION Of MEDICAI. SPECIALISTS Section of Surgery & European Board of Surgery Section & Board Divisions Working Groups NASCE Surgical Education News & Events UEMS Surgery • Divisions • Transplantation • Transplant Coordination • EBSQ Examination Divisions Schedule and App lication Certification of European Transplant Coordinator (CETC) Ge ne ral Surgery Coloproctology Date Place Application deadline tba tba tba Endocrine Surgery Transplantation Transplant Surgery Transplant Coordination EBSO Examination Application Form and Logbook for Certi fication of European Transplant Coordinator (CETC) Application form (pdf) Preparatory course Curriculum Fellows Application form (Word) Download Tack! www.ivo.se [email protected] [email protected] [email protected]
© Copyright 2024